Role of stent design and coatings on restenosis and thrombosis

被引:135
作者
Hara, Hidehiko
Nakamura, Masato
Palmaz, Julio C.
Schwartz, Robert S.
机构
[1] Minneapolis Heart Inst, Minnesota Cardiovasc Res Inst, Minneapolis, MN 55407 USA
[2] Minneapolis Heart Inst Fdn, Minneapolis, MN 55407 USA
[3] Toho Univ, Ohashi Hosp, Div Cardiovasc Med, Tokyo, Japan
[4] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
关键词
stent; stent design; drug eluting stent; restenosis;
D O I
10.1016/j.addr.2006.01.022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
More than 15 years have passed since stent technology was introduced by Sigwart et al. [U. Sigwart, J. Puel, V. Mirkovitch, F, Joffe, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N. Engl. J. Med. 3 16 (1987) 701-706] among interventional cardiologists. Recently drug eluting stents have assumed dominance in the interventional world as positive trial results revealed their efficacy for preventing restenosis. Stent design, delivery-vehicle materials, and drug properties affect the function of these stents. Stainless steel stents with tubular and multicellular design have proven superior to coil or hybrid stent models. This chapter describes stents which have Subtle influences of modular design, metal coverage, strut thickness, strut shape, surface smoothness, and coating materials like ail alloy composition. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:377 / 386
页数:10
相关论文
共 77 条
[1]  
Axel DI, 1997, CIRCULATION, V96, P636
[2]   Heparin coating of tantalum coronary stents reduces surface thrombin generation but not factor IXa generation [J].
Blezer, R ;
Cahalan, L ;
Cahalan, PT ;
Lindhout, T .
BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (05) :435-440
[3]   In-stent restenosis in small coronary arteries - Impact of strut thickness [J].
Briguori, C ;
Sarais, C ;
Pagnotta, P ;
Liistro, F ;
Montorfano, M ;
Chieffo, A ;
Sgura, F ;
Corvaja, N ;
Albiero, R ;
Stankovic, G ;
Toutoutzas, C ;
Bonizzoni, E ;
Di Mario, C ;
Colombo, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (03) :403-409
[4]  
Briguori C, 2000, CIRCULATION, V102, P3028
[5]  
Buellesfeld L, 2004, HERZ, V29, P167, DOI 10.1007/s00059-004-2557-5
[6]  
CARASIC JM, 2000, CIRCULATION, V101, P812
[7]  
Colombo A, 2000, CIRCULATION, V102, P371
[8]  
De Scheerder I, 1998, Semin Interv Cardiol, V3, P139
[9]  
DeScheerder I, 1997, CIRCULATION, V95, P1549
[10]  
Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x